- Thread starter Maggot
- Start date
like this one
www.ncbi.nlm.nih.gov
or maybe this one
www.justice.gov
or
www.businessweek.com/news/2010-03-23/pfizer-defends-epilepsy-drug-neurontin-at-fraud-trial-in-boston.html.
Tough on Crime? Pfizer and the CIHR
The appointment of Dr. Bernard Prigent, vice-president and medical director of Pfizer Canada, to the Governing Council of the Canadian Institutes of Health Research, outraged many Canadian health researchers. Pfizer has been a “habitual offender,” ...
www.ncbi.nlm.nih.gov or maybe this one
U.S. Files Suit Against Johnson & Johnson for Paying Kickbacks to Nation’s Largest Nursing Home Pharmacy
The United States has filed a civil False Claims Act complaint against drug manufacturer Johnson & Johnson (J&J) of New Brunswick, N.J., and two of its subsidiaries, Ortho-McNeil-Janssen Pharmaceuticals Inc. and Johnson & Johnson Health Care Systems Inc.
www.justice.gov or
www.businessweek.com/news/2010-03-23/pfizer-defends-epilepsy-drug-neurontin-at-fraud-trial-in-boston.html.
Then there is stuff like this
www.cbsnews.com
www.npr.org
Kinda funny Moderna which is NON known for vaccines all the sudden jumps into a market they know pretty much nothing about....
Watchdog urges SEC to investigate vaccine maker Moderna
Accountable.US told the agency that Moderna executives "exploited coronavirus fears" to boost their own stock wealth.
www.cbsnews.com 'Bad Optics' Or Something More? Moderna Executives' Stock Sales Raise Concerns
Moderna is currently developing a promising, yet still unproven, vaccine against the coronavirus. But Moderna executives have already sold tens of millions of dollars worth of stock in the company.
www.npr.org Kinda funny Moderna which is NON known for vaccines all the sudden jumps into a market they know pretty much nothing about....
Thats the one, thanks.
Conflict of interest much?
EDT
Pfizer Inc. today announced the election of James C. Smith to its Board of Directors, effective immediately. Mr. Smith also was appointed to the Corporate Governance and Science and Technology Committees of Pfizer’s Board.
Mr. Smith, 54, is the President and Chief Executive Officer (CEO) of Thomson Reuters and serves on its Board of Directors. Prior to his appointment as CEO in January 2012, he held various leadership positions at Thomson Reuters, including CEO and Chief Operating Officer (COO) of Thomson Reuters Professional Division. Prior to the acquisition of Reuters PLC by Thomson, he served as COO of Thomson and President and CEO of Thomson Learning’s Academic and Reference Group.
Mr. Smith is a member of the International Business Council of the World Economic Forum and the Board of Directors of the Brazil-U.S. Business Council. He also serves on the International Advisory Boards of British American Business and the Atlantic Council.
“We are pleased to have Jim Smith join Pfizer’s Board of Directors. He brings leadership and operational and international business experience to Pfizer’s Board, and will be an excellent asset to the company,” stated Ian Read, Pfizer’s Chairman and Chief Executive Officer. “The addition of Jim to our Board helps ensure that Pfizer will continue to benefit from a breadth and variety of experience.”
JAMES C. SMITH ELECTED TO PFIZER’S BOARD OF DIRECTORS
Thursday, June 26, 2014 - 05:45amEDT
Pfizer Inc. today announced the election of James C. Smith to its Board of Directors, effective immediately. Mr. Smith also was appointed to the Corporate Governance and Science and Technology Committees of Pfizer’s Board.
Mr. Smith, 54, is the President and Chief Executive Officer (CEO) of Thomson Reuters and serves on its Board of Directors. Prior to his appointment as CEO in January 2012, he held various leadership positions at Thomson Reuters, including CEO and Chief Operating Officer (COO) of Thomson Reuters Professional Division. Prior to the acquisition of Reuters PLC by Thomson, he served as COO of Thomson and President and CEO of Thomson Learning’s Academic and Reference Group.
Mr. Smith is a member of the International Business Council of the World Economic Forum and the Board of Directors of the Brazil-U.S. Business Council. He also serves on the International Advisory Boards of British American Business and the Atlantic Council.
“We are pleased to have Jim Smith join Pfizer’s Board of Directors. He brings leadership and operational and international business experience to Pfizer’s Board, and will be an excellent asset to the company,” stated Ian Read, Pfizer’s Chairman and Chief Executive Officer. “The addition of Jim to our Board helps ensure that Pfizer will continue to benefit from a breadth and variety of experience.”
All you need to do is look up lobbying statistics:
www.opensecrets.org
Notice how the "Health" and "Finance" ones are way above everything else.
Ranked Sectors
Health topped the list of economic sectors lobbied in 2022, with $537,324,722 total spent. See all economic sector totals.
www.opensecrets.org Notice how the "Health" and "Finance" ones are way above everything else.
I know people will read this evidence on vaccines, but take a step back for a second and realize:
THIS IS HOW BIG BUSINESS WORKS.
I'm not saying its ok, or even good--but if you didn't realize that all the directors and CEOs are screwing each other (figuratively and literaly) you haven't been paying attention.
Today its pharma, tommorow its GMOs, after that its Defense. We all talk big about meritocracy but all you have to do is look at the boards makeups and realize its all a good ol boys (now with 100% more diversity!) club.
What's the value of a Harvard Education?
Connections.
Look at the fustercluck that was Theranos (or whatever it was--the blood test company). Look at who was on the board while they milked us all.
www.businessinsider.com
Hey look where the military goes:
www.lockheedmartin.com
THIS IS HOW BIG BUSINESS WORKS.
I'm not saying its ok, or even good--but if you didn't realize that all the directors and CEOs are screwing each other (figuratively and literaly) you haven't been paying attention.
Today its pharma, tommorow its GMOs, after that its Defense. We all talk big about meritocracy but all you have to do is look at the boards makeups and realize its all a good ol boys (now with 100% more diversity!) club.
What's the value of a Harvard Education?
Connections.
Look at the fustercluck that was Theranos (or whatever it was--the blood test company). Look at who was on the board while they milked us all.
How Elizabeth Holmes convinced powerful men like Henry Kissinger, James Mattis, and George Shultz to sit on the board of now disgraced blood-testing startup Theranos
Theranos at one point had a star-studded board of directors, including military leaders and former secretaries of state.
www.businessinsider.com Hey look where the military goes:
Board of Directors
Lockheed Martin Board of Directors, Committee Memberships and Committee Charters.
omg, you almost can't get more deep state nwo than that without being george soros himself.Conflict of interest much?
JAMES C. SMITH ELECTED TO PFIZER’S BOARD OF DIRECTORS
Thursday, June 26, 2014 - 05:45am
EDT
Pfizer Inc. today announced the election of James C. Smith to its Board of Directors, effective immediately. Mr. Smith also was appointed to the Corporate Governance and Science and Technology Committees of Pfizer’s Board.
Mr. Smith, 54, is the President and Chief Executive Officer (CEO) of Thomson Reuters and serves on its Board of Directors. Prior to his appointment as CEO in January 2012, he held various leadership positions at Thomson Reuters, including CEO and Chief Operating Officer (COO) of Thomson Reuters Professional Division. Prior to the acquisition of Reuters PLC by Thomson, he served as COO of Thomson and President and CEO of Thomson Learning’s Academic and Reference Group.
Mr. Smith is a member of the International Business Council of the World Economic Forum and the Board of Directors of the Brazil-U.S. Business Council. He also serves on the International Advisory Boards of British American Business and the Atlantic Council.
“We are pleased to have Jim Smith join Pfizer’s Board of Directors. He brings leadership and operational and international business experience to Pfizer’s Board, and will be an excellent asset to the company,” stated Ian Read, Pfizer’s Chairman and Chief Executive Officer. “The addition of Jim to our Board helps ensure that Pfizer will continue to benefit from a breadth and variety of experience.”
